193 related articles for article (PubMed ID: 11313783)
1. Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery.
Tanaka M; Fraizer GC; De La Cerda J; Cristiano RJ; Liebert M; Grossman HB
Gene Ther; 2001 Jan; 8(2):139-48. PubMed ID: 11313783
[TBL] [Abstract][Full Text] [Related]
2. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions.
Vrionis FD; Wu JK; Qi P; Waltzman M; Cherington V; Spray DC
Gene Ther; 1997 Jun; 4(6):577-85. PubMed ID: 9231074
[TBL] [Abstract][Full Text] [Related]
3. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.
Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM
Gene Ther; 1997 Sep; 4(9):909-17. PubMed ID: 9349427
[TBL] [Abstract][Full Text] [Related]
4. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells.
Yang L; Chiang Y; Lenz HJ; Danenberg KD; Spears CP; Gordon EM; Anderson WF; Parekh D
Hum Gene Ther; 1998 Mar; 9(5):719-28. PubMed ID: 9551619
[TBL] [Abstract][Full Text] [Related]
5. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene.
Kim YG; Bi W; Feliciano ES; Drake RR; Stambrook PJ
Cancer Gene Ther; 2000 Feb; 7(2):240-6. PubMed ID: 10770632
[TBL] [Abstract][Full Text] [Related]
6. Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.
Xiao J; Zhang G; Li B; Wu Y; Liu X; Tan Y; Du B
Oncotarget; 2017 Jan; 8(1):798-807. PubMed ID: 27903977
[TBL] [Abstract][Full Text] [Related]
7. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
8. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
[TBL] [Abstract][Full Text] [Related]
9. Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer.
Matono S; Tanaka T; Sueyoshi S; Yamana H; Fujita H; Shirouzu K
Int J Oncol; 2003 Nov; 23(5):1309-15. PubMed ID: 14532970
[TBL] [Abstract][Full Text] [Related]
10. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
[TBL] [Abstract][Full Text] [Related]
11. Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects.
Nicholas TW; Read SB; Burrows FJ; Kruse CA
Histol Histopathol; 2003 Apr; 18(2):495-507. PubMed ID: 12647801
[TBL] [Abstract][Full Text] [Related]
12. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma.
Ghoumari AM; Mouawad R; Zerrouqi A; Nizard C; Provost N; Khayat D; Naus CC; Soubrane C
Gene Ther; 1998 Aug; 5(8):1114-21. PubMed ID: 10326035
[TBL] [Abstract][Full Text] [Related]
13. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
14. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
15. Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro.
Elshami AA; Saavedra A; Zhang H; Kucharczuk JC; Spray DC; Fishman GI; Amin KM; Kaiser LR; Albelda SM
Gene Ther; 1996 Jan; 3(1):85-92. PubMed ID: 8929915
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of intercellular communication of poor-communicating cells by gap-junction-competent cells enhances the HSV-TK/GCV bystander effect in vitro.
Tanaka T; Yamasaki H; Mesnil M
Int J Cancer; 2001 Feb; 91(4):538-42. PubMed ID: 11251978
[TBL] [Abstract][Full Text] [Related]
17. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
Marconi P; Tamura M; Moriuchi S; Krisky DM; Niranjan A; Goins WF; Cohen JB; Glorioso JC
Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.
Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G
Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells.
Namba H; Iwadate Y; Kawamura K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Jun; 8(6):414-20. PubMed ID: 11498761
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communication.
Xiao J; Zhang G; Qiu P; Liu X; Wu Y; Du B; Li J; Zhou J; Li J; Tan Y
PLoS One; 2013; 8(7):e67662. PubMed ID: 23861780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
